Search Results

Suggested Topics within your search.
Refine Results
  1. 1
    Detection of BRAF p.V600E Mutations in Melanomas

    Detection of BRAF p.V600E Mutations in Melanomas by Émeline Colomba, Zofia Hélias‐Rodzewicz, Andreas von Deimling, Cristi Marin, Nathalie Terrones, Dominique Pechaud, Sylvie Surel, Jean‐François Côté, Frédérique Peschaud, David Capper, Hélène Blons, U. Zimmermann, T. Clérici, Philippe Saïag, Jean‐François Emile

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical study

    BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical study by Giovanni Tallini, Dario de Biase, Cosimo Durante, Giorgia Acquaviva, Michele Bisceglia, Rocco Bruno, Maria Letizia Bacchi Reggiani, Gian Piero Casadei, Giuseppe Costante, Nadia Cremonini, Livia Lamartina, Domenico Meringolo, Francesco Nardi, Annalisa Pession, Kerry J. Rhoden, Giuseppe Ronga, Massimo Torlontano, Antonella Verrienti, Michela Visani, Sébastiano Filetti

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    <i>KIAA1549‐BRAF</i>Fusions and IDH Mutations Can Coexist in Diffuse Gliomas of Adults

    <i>KIAA1549‐BRAF</i>Fusions and IDH Mutations Can Coexist in Diffuse Gliomas of Adults by Manuela Badiali, Vincent Gleize, Sophie Paris, Loredana Moi, Selma Elhouadani, Antonietta Arcella, Roberta Morace, Manila Antonelli, Francesca Romana Buttarelli, Dominique Figarella Branger, Young Ho Kim, Hiroko Ohgaki, Karima Mokhtari, Marc Sanson, Felice Giangaspero

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Targeting RAS/RAF/MEK/ERK signaling in metastatic melanoma

    Targeting RAS/RAF/MEK/ERK signaling in metastatic melanoma by Aoxue Wang, Xiaoyi Qi

    Published 2013
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Clinical characteristics and outcomes with specific <i>BRAF</i> and <i>NRAS</i> mutations in patients with metastatic melanoma

    Clinical characteristics and outcomes with specific <i>BRAF</i> and <i>NRAS</i> mutations in patients with metastatic melanoma by Amanda D. Bucheit, Erica Syklawer, John Jakob, Roland L. Bassett, Jonathan L. Curry, Jeffrey E. Gershenwald, Kevin B. Kim, Patrick Hwu, Alexander J. Lazar, Michael A. Davies

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Preoperative BRAF(V600E) mutation screening is unlikely to alter initial surgical treatment of patients with indeterminate thyroid nodules

    Preoperative BRAF(V600E) mutation screening is unlikely to alter initial surgical treatment of patients with indeterminate thyroid nodules by David A. Kleiman, Matthew J. Sporn, Toni Beninato, Michael J. Crowley, Anvy Nguyen, Alessia Uccelli, Theresa Scognamiglio, Rasa Zarnegar, Thomas J. Fahey

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    High frequency of <scp>BRAF</scp><scp>V600E</scp> mutations in ameloblastoma

    High frequency of <scp>BRAF</scp><scp>V600E</scp> mutations in ameloblastoma by Kari J. Kurppa, Javier Catón, Peter R. Morgan, Ari Ristimäki, Blandine Ruhin, Jari Kellokoski, Klaus Elenius, Kristiina Heikinheimo

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Detection of BRAF V600E Mutation in Colorectal Cancer

    Detection of BRAF V600E Mutation in Colorectal Cancer by Susana Benlloch, Artemio Payá, Cristina Alenda, Xavier Bessa, Montserrat Andreu, Rodrigo Jover, Antoni Castells, Xavier Llor, Ignacio Aranda, Bartomeu Massutí

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Clinicopathologic significance of <i>BRAF</i> V600E mutation in papillary carcinomas of the thyroid

    Clinicopathologic significance of <i>BRAF</i> V600E mutation in papillary carcinomas of the thyroid by Jeong Hyeon Lee, Eung‐Seok Lee, Young‐Sik Kim

    Published 2007
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    Oncogene-induced senescence underlies the mutual exclusive nature of oncogenic KRAS and BRAF

    Oncogene-induced senescence underlies the mutual exclusive nature of oncogenic KRAS and BRAF by Jarosław Cisowski, Volkan I. Sayin, Meng Liu, C. Karlsson, Martin O. Bergö

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Validation of the <scp>VE1</scp> immunostain for the <i><scp>BRAF</scp></i><scp>V600E</scp> mutation in melanoma

    Validation of the <scp>VE1</scp> immunostain for the <i><scp>BRAF</scp></i><scp>V600E</scp> mutation in melanoma by Michelle V. Pearlstein, Daniel C. Zedek, David W. Ollila, Amanda L. Treece, Margaret L. Gulley, Pamela A. Groben, Nancy E. Thomas

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Targeting Oncogenic BRAF in Human Cancer

    Targeting Oncogenic BRAF in Human Cancer by Christine A. Pratilas, Feng Xing, David B. Solit

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    PLX4032, a potent inhibitor of the B‐Raf V600E oncogene, selectively inhibits V600E‐positive melanomas

    PLX4032, a potent inhibitor of the B‐Raf V600E oncogene, selectively inhibits V600E‐positive melanomas by John Tayu Lee, Ling Li, Patricia Brafford, Marcia van den Eijnden, Molly B. Halloran, Katrin Sproesser, Nikolas K. Haass, Keiran S.M. Smalley, James Tsai, Gideon Bollag, Meenhard Herlyn

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Variations of BRAF mutant allele percentage in melanomas

    Variations of BRAF mutant allele percentage in melanomas by Zofia Hélias‐Rodzewicz, Elisa Funck‐Brentano, L. Baudoux, Chan Kwon Jung, U. Zimmermann, Cristi Marin, T. Clérici, Catherine Le Gall, Frédérique Peschaud, Valérie Taly, Philippe Saïag, Jean‐François Emile

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Dysembryoplastic Neuroepithelial Tumors Share with Pleomorphic Xanthoastrocytomas and Gangliogliomas <scp>BRAF<sup>V600E</sup></scp> Mutation and Expression

    Dysembryoplastic Neuroepithelial Tumors Share with Pleomorphic Xanthoastrocytomas and Gangliogliomas <scp>BRAF<sup>V600E</sup></scp> Mutation and Expression by Céline Chappé, Laëtitia Padovani, Didier Scavarda, Fabien Forest, Isabelle Nanni‐Metellus, Anderson Loundou, Sandy Mercurio, Frédéric Fina, G. Léna, Carole Colin, Dominique Figarella‐Branger

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Targeted Therapy for Patients with BRAF-Mutant Lung Cancer Results from the European EURAF Cohort

    Targeted Therapy for Patients with BRAF-Mutant Lung Cancer Results from the European EURAF Cohort by Oliver Gautschi, Julie Milia, Bastien Cabarrou, M.V. Bluthgen, Benjamin Besse, Egbert F. Smit, Juergen Wolf, Solange Peters, Martin Früh, Dieter Koeberle, Youssouf Oulkhouir, Martin Schüler, Alessandra Curioni‐Fontecedro, Benjamin Huret, M. Kerjouan, Sebastian Michels, Georg Pall, Sacha I. Rothschild, Gerald Schmid‐Bindert, Matthias Scheffler, Rémi Veillon, Luciano Wannesson, Joachim Diebold, Gérard Zalcman, Thomas Filleron, Julien Mazières

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Potential clinical implications of<i>BRAF</i>mutations in histiocytic proliferations

    Potential clinical implications of<i>BRAF</i>mutations in histiocytic proliferations by Anna-Maria Bubolz, Stephanie E. Weissinger, Albrecht Stenzinger, Annette Arndt, Konrad Steinestel, Silke Brüderlein, Holger Cario, Anneli Lubatschofski, Claudia Welke, Ioannis Anagnostopoulos, Thomas F.E. Barth, Ambros J. Beer, Peter M√oller, M. H. Gottstein, Andreas Viardot, Jochen K. Lennerz

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Mutation‐specific antibody detects mutant BRAF<sup>V600E</sup> protein expression in human colon carcinomas

    Mutation‐specific antibody detects mutant BRAF<sup>V600E</sup> protein expression in human colon carcinomas by Frank A. Sinicrope, Thomas C. Smyrk, David Tougeron, Stephen N. Thibodeau, Shalini Singh, Andrea Murányi, Kandavel Shanmugam, Thomas M. Grogan, Steven R. Alberts, Qian Shi

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Distinct requirement for an intact dimer interface in wild-type, V600E and kinase-dead B-Raf signalling

    Distinct requirement for an intact dimer interface in wild-type, V600E and kinase-dead B-Raf signalling by Michael Röring, Ricarda Herr, Gina J. Fiala, Katharina Heilmann, Sandra Braun, Anja E. Eisenhardt, Sebastian Halbach, David Capper, Andreas von Deimling, Wolfgang W. Schamel, Darren N. Saunders, Tilman Brummer

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    <i>BRAF</i> V600E mutations in urine and plasma cell-free DNA from patients with Erdheim-Chester disease

    <i>BRAF</i> V600E mutations in urine and plasma cell-free DNA from patients with Erdheim-Chester disease by Filip Janků, Cecile Rose T. Vibat, Karena Kosco, Veronica R. Holley, Goran Cabrilo, Funda Meric‐Bernstam, Vanda M. Stepanek, Patrick P. Lin, Lorieta Leppin, Latifa Hassaine, Jason C. Poole, Razelle Kurzrock, Mark G. Erlander

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: